Home / Market News / $UNH
benzinga Corporate Catalyst Impact 55/100 ● negative

Bernstein Maintains Outperform on UnitedHealth Group, Lowers Price Target to $500

Oct 16, 2026, 5:05 PM UTC · Primary ticker $UNH

Bernstein analyst Lance Wilkes reiterated an 'Outperform' rating on UnitedHealth Group (UNH) but reduced the price target from $512 to $500. This indicates a slightly less optimistic outlook on the stock's near-term valuation, though the fundamental positive view remains.

Bernstein analyst Lance Wilkes maintained an 'Outperform' rating on UnitedHealth Group (UNH), signaling continued confidence in the company's long-term prospects. However, the price target was lowered from $512 to $500, suggesting a slight recalibration of near-term valuation expectations. This adjustment could be due to various factors, such as revised industry outlooks, competitive pressures, or changes in the analyst's financial models. For traders, this represents a moderate negative signal in the short term, as a lower price target might temper immediate upward momentum. Long-term investors might view this as a minor adjustment, given the maintained 'Outperform' rating, but it warrants monitoring for any further analyst revisions or company-specific news that could explain the change.

$UNH negative Price target lowered
Source: benzinga
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.